These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 1147

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mechanism of inactivation of glutamine amidotransferases by the antitumor drug L-(alpha S, 5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (AT-125).
    Tso JY, Bower SG, Zalkin H.
    J Biol Chem; 1980 Jul 25; 255(14):6734-8. PubMed ID: 6993476
    [Abstract] [Full Text] [Related]

  • 8. Acivicin. An antitumor antibiotic.
    Poster DS, Bruno S, Penta J, Neil GL, McGovren JP.
    Cancer Clin Trials; 1981 Jul 25; 4(3):327-30. PubMed ID: 7026076
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The inhibition of gamma-glutamyl transpeptidase and glutathione metabolism of isolated rat kidney cells by L-(alpha S, 5S)-alpha-amino-3-chloro-4, 5-dihydro-5-isoxazoleacetic acid (AT-125; NSC-163501).
    Reed DJ, Ellis WW, Meck RA.
    Biochem Biophys Res Commun; 1980 Jun 30; 94(4):1273-7. PubMed ID: 6104962
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Inhibition of cell cycle progression of human pancreatic carcinoma cells in vitro by L-(alpha S, 5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid, Acivicin (NSC 163501).
    Meck RA, Clubb KJ, Allen LM, Yunis AA.
    Cancer Res; 1981 Nov 30; 41(11 Pt 1):4547-53. PubMed ID: 7306976
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Monocytoid differentiation of freshly isolated human myeloid leukemia cells and HL-60 cells induced by the glutamine antagonist acivicin.
    Nichols KE, Chitneni SR, Moore JO, Weinberg JB.
    Blood; 1989 Oct 30; 74(5):1728-37. PubMed ID: 2790198
    [Abstract] [Full Text] [Related]

  • 15. Cytotoxic mechanisms of glutamine antagonists in mouse L1210 leukemia.
    Lyons SD, Sant ME, Christopherson RI.
    J Biol Chem; 1990 Jul 05; 265(19):11377-81. PubMed ID: 2358467
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Inactivation by acivicin of carbamoyl-phosphate synthetase II of human colon carcinoma.
    Sebolt JS, Aoki T, Eble JN, Glover JL, Weber G.
    Biochem Pharmacol; 1985 Jan 01; 34(1):97-100. PubMed ID: 3966920
    [Abstract] [Full Text] [Related]

  • 20. Aspects of glutamine metabolism in human tumour cells.
    Colquhoun A, Newsholme EA.
    Biochem Mol Biol Int; 1997 Mar 01; 41(3):583-96. PubMed ID: 9090467
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.